LPL Financial’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-156
| Closed | -$1.66K | – | 5020 |
|
|
2023
Q4 | $1.66K | Buy |
+156
| New | +$1.88K | ﹤0.01% | 4788 |
|
|
2022
Q1 | – | Sell |
-76
| Closed | -$12K | – | 4383 |
|
|
2021
Q4 | $12K | Sell |
76
-16
| -17% | -$3.52K | ﹤0.01% | 4314 |
|
|
2021
Q3 | $25K | Sell |
92
-111
| -55% | -$33.9K | ﹤0.01% | 4275 |
|
|
2021
Q2 | $80K | Sell |
203
-14
| -6% | -$6.54K | ﹤0.01% | 4092 |
|
|
2021
Q1 | $117K | Sell |
217
-7
| -3% | -$4.36K | ﹤0.01% | 3894 |
|
|
2020
Q4 | $85K | Sell |
224
-68
| -23% | -$27K | ﹤0.01% | 3701 |
|
|
2020
Q3 | $110K | Buy |
292
+9
| +3% | +$3.98K | ﹤0.01% | 3350 |
|
|
2020
Q2 | $139K | Buy |
283
+22
| +8% | +$9.81K | ﹤0.01% | 3228 |
|
|
2020
Q1 | $96K | Sell |
261
-6
| -2% | -$3.1K | ﹤0.01% | 3001 |
|
|
2019
Q4 | $189K | Sell |
267
-3
| -1% | -$2.06K | ﹤0.01% | 3116 |
|
|
2019
Q3 | $174K | Sell |
270
-23
| -8% | -$18.2K | ﹤0.01% | 3046 |
|
|
2019
Q2 | $256K | Buy |
293
+7
| +2% | +$4.81K | ﹤0.01% | 2832 |
|
|
2019
Q1 | $165K | Buy |
286
+5
| +2% | +$2.09K | ﹤0.01% | 2998 |
|
|
2018
Q4 | $79K | Sell |
281
-23
| -8% | -$9.09K | ﹤0.01% | 2978 |
|
|
2018
Q3 | $146K | Sell |
304
-11
| -3% | -$4.72K | ﹤0.01% | 3069 |
|
|
2018
Q2 | $142K | Buy |
315
+3
| +1% | +$1.9K | ﹤0.01% | 3066 |
|
|
2018
Q1 | $183K | Buy |
312
+3
| +1% | +$1.87K | ﹤0.01% | 2978 |
|
|
2017
Q4 | $192K | Buy |
309
+222
| +255% | +$160K | ﹤0.01% | 2832 |
|
|
2017
Q3 | $80K | Hold |
87
| – | – | ﹤0.01% | 2793 |
|
|
2017
Q2 | $81K | Sell |
87
-1
| -1% | -$980 | ﹤0.01% | 2728 |
|
|
2017
Q1 | $83K | Buy |
+88
| New | +$81.9K | ﹤0.01% | 2630 |
|
|
2016
Q4 | – | Sell |
-81
| Closed | -$69K | – | 2778 |
|
|
2016
Q3 | $69K | Buy |
81
+1
| +1% | +$804 | ﹤0.01% | 2562 |
|
|
2016
Q2 | $72K | Sell |
80
-188
| -70% | -$205K | ﹤0.01% | 2536 |
|
|
2016
Q1 | $311K | Buy |
268
+101
| +60% | +$103K | ﹤0.01% | 2481 |
|
|
2015
Q4 | $200K | Buy |
+167
| New | +$276K | ﹤0.01% | 2825 |
|
|
2014
Q4 | – | Sell |
-68
| Closed | -$26K | – | 2790 |
|
|
2014
Q3 | $26K | Buy |
+68
| New | +$32.8K | ﹤0.01% | 2665 |
|
|
2014
Q2 | – | Sell |
-88
| Closed | -$60K | – | 2744 |
|
|
2014
Q1 | $60K | Sell |
88
-13
| -13% | -$8.71K | ﹤0.01% | 2581 |
|
|
2013
Q4 | $66K | Sell |
101
-5
| -5% | -$2.98K | ﹤0.01% | 2586 |
|
|
2013
Q3 | $69K | Hold |
106
| – | – | ﹤0.01% | 2477 |
|
|
2013
Q2 | $34K | Buy |
+106
| New | +$29.4K | ﹤0.01% | 2383 |
|
Other funds holding TCRT
MP
CB
ACM
LPL Financial's TCRT Position: Q1 2024 in Review
LPL Financial sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 156 shares — an estimated $1.66K sold.
LPL Financial first reported a position in TCRT in Q2 2013 and held it in 30 quarters. The position peaked at $311K in Q1 2016. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.
- LPL Financial reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
- LPL Financial sold 156 Alaunos Therapeutics shares in Q1 2024, an estimated $1.66K.
- LPL Financial first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 30 quarters.
- LPL Financial's Alaunos Therapeutics position peaked at $311K in Q1 2016.
- 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.
Based on LPL Financial's 13F filing for Q1 2024, filed 10 May 2024.